Michael Jerman
Fortuna: 51 274 $ al 31/05/2026
Fortuna: 51 274 $ al 31/05/2026
Mr. Michael A. Jerman is an Independent Director at Alaunos Therapeutics, Inc., an Independent Director at Inhibitor Therapeutics, Inc. and a Managing Partner at Hollywell Partners LLC.
He is on the Board of Directors at Alaunos Therapeutics, Inc. and Inhibitor Therapeutics, Inc. Mr. Jerman was previously employed as an Independent Director by MIRA Pharmaceuticals, Inc. and an Independent Director by Telomir Pharmaceuticals, Inc. He also served on the board at PricewaterhouseCoopers LLP.
He received his undergraduate degree from the University of South Florida, a graduate degree from The University of Tampa, Inc. and an MBA from the University of Oxford.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/04/2026 | 15.621 ( 0,64 % ) | 44 520 $ | 31/05/2026 | |
| 01/04/2025 | 80.411 ( 0,05 % ) | 6 755 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Director/Miembro de la Junta | 24/05/2023 |
| ALAUNOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/07/2025 |
HOLLYWELL PARTNERS LLC
HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Corporate Officer/Principal | 01/05/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 18/11/2024 |
| MIRA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 18/11/2024 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Director/Miembro de la Junta | 01/08/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tampa, Inc.
The University of Tampa, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
HOLLYWELL PARTNERS LLC
HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Commercial Services |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.